Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

ClinicalTrials.gov ID: NCT01130493

Public ClinicalTrials.gov record NCT01130493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 in Advanced Parkinson's Disease

Study identification

NCT ID
NCT01130493
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Impax Laboratories, LLC
Industry
Enrollment
110 participants

Conditions and interventions

Interventions

  • IPX066 Drug
  • CLE Drug

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Oct 28, 2019

2010 – 2012

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Margolin Brain Institute Fresno California 93720
The Parkinson's Institute in Sunnyvale Sunnyvale California 94085
UM Movement Disorders Center Miami Florida 33136
Charlotte Neurological Services Port Charlotte Florida 33980
USF Parkinson's and Movement Disorders Center Tampa Florida 33606
Quest Research Institute Bingham Farms Michigan 48025
University Health Systems Las Vegas Nevada 89102
Parkinson's Disease and Movement Disorders Center of Long Island Commack New York 11725
Kingston Neurological Associates Kingston New York 12401
University Neurology, Inc Cincinnati Ohio 45219
Sentara Neurological Associates Virginia Beach Virginia 23456
Booth Gardner Parkinson's Care Center Kirkland Washington 98034

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01130493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2019 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01130493 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →